Electrochemical Biosensing Techniques for Glycated Hemoglobin Detection

Glycated haemoglobin (HbA1c) serves as a critical biomarker for long-term glucose control in diabetes management, reflecting average blood sugar levels over two to three months. Electrochemical biosensing approaches exploit the conversion of biochemical interactions at an electrode interface into measurable electrical signals, offering rapid, sensitive and cost-effective analysis compatible with point-of-care testing. Central to these methods are recognition elements—such as antibodies, boronic acids or engineered enzymes—that selectively bind or transform HbA1c or its proteolytic fragments. Signal transduction modes vary from amperometric and voltammetric measurements to impedance spectroscopy, each providing distinct advantages in sensitivity, dynamic range and resistance to biofouling. Integration of nanostructured materials—gold nanoparticles, carbon nanotubes or metal–organic frameworks—enhances electrode conductivity and surface area, thereby improving detection limits and response times. Advances in miniaturised fabrication and disposable electrodes are paving the way for decentralised monitoring platforms capable of delivering clinically relevant HbA1c results with minimal sample preparation and simplified user operation.

Research from Nature Portfolio

Structural insights into fructosyl peptide oxidase (FPOX) have elucidated key residues that govern substrate access and oxygen diffusion within the active site. High-resolution X-ray crystallography of wild-type and mutant enzymes revealed a gating mechanism whereby specific amino acids maintain an optimal channel for oxygen, informing the design of more efficient FPOX variants for biosensing applications. Building on these findings, protein engineering has yielded a novel HbA1c direct oxidase by modifying the FPOX active-site entrance to accommodate intact glycated haemoglobin without prior proteolysis. Site-directed mutagenesis and random library screening produced an enzyme variant with enhanced reactivity towards the HbA1c N-terminal peptide, enabling a single-step electrochemical assay. This protease-free system demonstrates strong correlation with conventional chromatographic methods and offers a streamlined platform for in vitro diagnostics, reducing assay complexity and turnaround time.

Electrochemical Biosensing Techniques for Glycated Hemoglobin Detection publication trend

The graph below shows the total number of articles in electrochemical biosensing techniques for glycated hemoglobin detection across all publications each year (not limited to Nature Index journals).

Technical terms

Glycated haemoglobin (HbA1c): Haemoglobin whose N-terminal valine is non-enzymatically modified by glucose, indicating average glycaemia over weeks to months.

Electrochemical biosensor: Analytical device converting a biological recognition event into an electrical signal via a transducer and electrode interface.

Amperometry: Technique measuring current resulting from redox reactions at a fixed electrode potential, proportional to analyte concentration.

Voltammetry: Method recording current response as electrode potential is swept, yielding peak currents characteristic of the analyte’s redox behaviour.

Electrochemical impedance spectroscopy (EIS): Analysis of electrode resistance and capacitance over a range of frequencies to probe interfacial kinetics and surface fouling.

Boronic acid recognition: Reversible covalent interaction between boronic acid moieties and cis-diol groups on glycated proteins, enabling selective capture of HbA1c.

Fructosyl peptide oxidase (FPOX): FAD-dependent enzyme that oxidises fructosyl peptides derived from HbA1c, producing a measurable electroactive species for detection.

References

1. Recent advances in gold nanostructure-based biosensors in detecting diabetes biomarkers. Frontiers in Bioengineering and Biotechnology (2024).
2. A Review of Electrochemical Sensors for the Detection of Glycated Hemoglobin. Biosensors (2022).
3. X-ray structures of fructosyl peptide oxidases revealing residues responsible for gating oxygen access in the oxidative half reaction. Scientific Reports (2017).
4. A Carbon-Based Antifouling Nano-Biosensing Interface for Label-Free POCT of HbA1c. Biosensors (2021).
5. Creation of haemoglobin A1c direct oxidase from fructosyl peptide oxidase by combined structure-based site specific mutagenesis and random mutagenesis. Scientific Reports (2019).